Weekly Digest - Jan 2024
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
Weekly Digest - Jan 2024
16 Jan 2024: LegoChem secures $411M funding from confectionery firm in ADC advancement
- LegoChem Bioscience, fueled by a $411 million investment from Orion, is expanding its R&D efforts in the rapidly evolving field of ADCs
- LegoChem has adjusted its R&D targets by ~150%, with Orion supporting a deal to acquire around 25% of the biotech
- LegoChem’s plan to invest $747 million in R&D over the next five years, fills a financial gap and positions the biotech to advance its clinical pipeline targeting popular ADCs such as HER2, Gilead’s TROP2, ROR1, CD19, and DLK1
- LegoChem aims to accomplish its goals: discovering two drug candidates annually and initiating five phase 1 clinical trials within the next five years with cash infusion from Orion
